ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.38
0.74%
US Tech 100
20,836.00
1.31%
S&P 500
5,930.85
1.09%
US Dollar vs CAD
1.43421
0.00%
Bitcoin
97,078.59
-0.13%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AbCellera Biologics Inc (ABCL)

  7. AbCellera Biologics Inc (ABCL) News

ABCL

AbCellera Biologics (ABCL)

AbCellera Biologics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABCL
DateTimeSourceHeadlineSymbolCompany
12/05/20243:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
11/26/20244:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
11/21/20243:05PMBusiness WireAbCellera to Present at Upcoming Investor Conferences in December and JanuaryNASDAQ:ABCLAbCellera Biologics Inc
11/07/20249:05AMBusiness WireAbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024NASDAQ:ABCLAbCellera Biologics Inc
11/04/20243:34PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABCLAbCellera Biologics Inc
11/04/20243:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
11/04/20243:05PMBusiness WireAbCellera Reports Q3 2024 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
10/22/20243:05PMBusiness WireAbCellera to Present at Upcoming Investor Conferences in November 2024NASDAQ:ABCLAbCellera Biologics Inc
10/04/20248:00AMBusiness WireAbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024NASDAQ:ABCLAbCellera Biologics Inc
09/26/20243:05PMBusiness WireAbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024NASDAQ:ABCLAbCellera Biologics Inc
09/24/20243:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
08/29/20243:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
08/29/20243:05PMBusiness WireAbCellera to Present at Upcoming Investor Conferences in SeptemberNASDAQ:ABCLAbCellera Biologics Inc
08/06/20243:55PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABCLAbCellera Biologics Inc
08/06/20243:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
08/06/20243:05PMBusiness WireAbCellera Reports Q2 2024 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
07/31/20248:00AMBusiness WireAbCellera and Lilly Expand Collaboration to Develop Antibody MedicinesNASDAQ:ABCLAbCellera Biologics Inc
06/25/20243:05PMBusiness WireAbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024NASDAQ:ABCLAbCellera Biologics Inc
06/13/20243:53PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
06/03/20243:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
05/28/20243:05PMBusiness WireAbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024NASDAQ:ABCLAbCellera Biologics Inc
05/07/20243:47PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABCLAbCellera Biologics Inc
05/07/20243:22PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
05/07/20243:05PMBusiness WireAbCellera Reports Q1 2024 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
05/01/20248:00AMBusiness WireAbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech CompaniesNASDAQ:ABCLAbCellera Biologics Inc
04/08/202411:05AMBusiness WireAbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024NASDAQ:ABCLAbCellera Biologics Inc
04/03/20243:05PMBusiness WireAbCellera to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:ABCLAbCellera Biologics Inc
03/19/20243:05PMBusiness WireAbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024NASDAQ:ABCLAbCellera Biologics Inc
03/11/20248:00AMBusiness WireAbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological ConditionsNASDAQ:ABCLAbCellera Biologics Inc
03/05/20243:30PMBusiness WireAbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024NASDAQ:ABCLAbCellera Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:ABCL

Your Recent History

LSE
SCSP
Seed Capital Solutions
BIT
UC27EQ
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads